{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:44:13Z","timestamp":1790772253411,"version":"4.1.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Achieving tolerance toward factor VIII (FVIII) remains an important goal of hemophilia treatment. Up to 40% of patients with severe hemophilia A (HA) develop neutralizing antibodies against FVIII, and the only proven treatment to achieve tolerance is infusion of FVIII over prolonged periods in the context of immune tolerance induction. Here, we addressed the role of von Willebrand factor (VWF) as a modulator of anti-FVIII antibody effector functions and the FVIII-specific recall response in an HA mouse model. Analytical ultracentrifugation was used to demonstrate formation of FVIII-containing immune complexes (FVIII-ICs). VWF did not fully prevent FVIII-IC formation but was rather incorporated into larger macromolecular complexes. VWF prevented binding of FVIII-ICs to complement C1q, most efficiently when it was preincubated with FVIII before the addition of antibodies. It also prevented binding to immobilized Fc-\u03b3 receptor and to bone marrow\u2013derived dendritic cells. An in\u00a0vitro model of the anti-FVIII recall response demonstrated that addition of VWF to FVIII abolished the proliferation of FVIII-specific antibody-secreting cells. After adoptive transfer of sensitized splenocytes into immunocompetent HA mice, the FVIII recall response was diminished by VWF. In summary, these data indicate that VWF modulates the formation and effector functions of FVIII-ICs and attenuates the secondary immune response to FVIII in HA mice.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010388","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T15:11:38Z","timestamp":1695827498000},"page":"6771-6781","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8066-0599","authenticated-orcid":false,"given":"Olga","family":"Oleshko","sequence":"first","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Vollack-Hesse","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-8536","authenticated-orcid":false,"given":"Andreas","family":"Tiede","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hegermann","sequence":"additional","affiliation":[{"name":"2Research Core Unit Electron Microscopy, Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Curth","sequence":"additional","affiliation":[{"name":"3Institute for Biophysical Chemistry, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Werwitzke","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"issue":"21","key":"2023111415103707400_bib1","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","article-title":"A\u00a0randomized trial of factor VIII and neutralizing antibodies in hemophilia A","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"2023111415103707400_bib2","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood-2017-08-801662","article-title":"Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?","volume":"130","author":"Lenting","year":"2017","journal-title":"Blood"},{"issue":"10274","key":"2023111415103707400_bib3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0140-6736(20)32722-7","article-title":"The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing","volume":"397","author":"Mancuso","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"2023111415103707400_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/hae.13762","article-title":"The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab","volume":"25","author":"Carcao","year":"2019","journal-title":"Haemophilia"},{"issue":"6","key":"2023111415103707400_bib5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"The principal results of the International Immune Tolerance Study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2023111415103707400_bib6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2015-04-641688","article-title":"Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry","volume":"126","author":"Chiu","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2023111415103707400_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood-2015-06-652073","article-title":"FVIII-VWF dos-a-dos","volume":"126","author":"Krishnaswamy","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2023111415103707400_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1182\/blood-2008-02-124941","article-title":"Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A","volume":"112","author":"Lacroix-Desmazes","year":"2008","journal-title":"Blood"},{"issue":"16","key":"2023111415103707400_bib9","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2023111415103707400_bib10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2006-05-022756","article-title":"VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors","volume":"109","author":"Dasgupta","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2023111415103707400_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3324\/haematol.2015.137067","article-title":"von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII","volume":"101","author":"Sorvillo","year":"2016","journal-title":"Haematologica"},{"issue":"2","key":"2023111415103707400_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2516.2011.02679.x","article-title":"Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A","volume":"18","author":"Delignat","year":"2012","journal-title":"Haemophilia"},{"issue":"4","key":"2023111415103707400_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/bjh.12942","article-title":"Effect of von Willebrand factor on inhibitor eradication in patients with severe haemophilia A: a systematic review","volume":"166","author":"van Velzen","year":"2014","journal-title":"Br J Haematol"},{"key":"2023111415103707400_bib14","first-page":"201","article-title":"Antibodies as natural adjuvants","volume":"382","author":"Heyman","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"2023111415103707400_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jth.13570","article-title":"Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells","volume":"15","author":"Hartholt","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2023111415103707400_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1365-2516.2003.00802.x","article-title":"Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in\u00a0vitro","volume":"9","author":"Astermark","year":"2003","journal-title":"Haemophilia"},{"key":"2023111415103707400_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-1-0716-1197-5_19","article-title":"Analytical ultracentrifugation for analysis of protein-nucleic acid interactions","volume":"2263","author":"Bogutzki","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2023111415103707400_bib18","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","article-title":"Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling","volume":"78","author":"Schuck","year":"2000","journal-title":"Biophys J"},{"key":"2023111415103707400_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.mie.2015.05.001","article-title":"Calculations and publication-quality illustrations for analytical ultracentrifugation data","volume":"562","author":"Brautigam","year":"2015","journal-title":"Methods Enzymol"},{"issue":"2","key":"2023111415103707400_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/sji.12573","article-title":"Anti-FcgammaRIIB (CD32) antibodies differentially modulate murine FVIII-specific recall response in\u00a0vitro","volume":"86","author":"Vollack","year":"2017","journal-title":"Scand J Immunol"},{"issue":"6","key":"2023111415103707400_bib21","first-page":"1127","article-title":"Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in\u00a0vitro","volume":"114","author":"Werwitzke","year":"2015","journal-title":"Thromb Haemost"},{"issue":"9","key":"2023111415103707400_bib22","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1160\/TH17-03-0201","article-title":"CD32 inhibition and high dose of rhFVIII suppress murine FVIII-specific recall response by distinct mechanisms in\u00a0vitro","volume":"117","author":"Vollack","year":"2017","journal-title":"Thromb Haemost"},{"issue":"10","key":"2023111415103707400_bib23","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2005-03-1182","article-title":"High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors","volume":"106","author":"Hausl","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2023111415103707400_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"issue":"9","key":"2023111415103707400_bib25","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1182\/blood.V88.9.3446.bloodjournal8893446","article-title":"Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies","volume":"88","author":"Bi","year":"1996","journal-title":"Blood"},{"issue":"4","key":"2023111415103707400_bib26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1258\/la.2008.008057","article-title":"DNA analysis from stool samples: a fast and reliable method avoiding invasive sampling methods in mouse models of bleeding disorders","volume":"43","author":"Kalippke","year":"2009","journal-title":"Lab Anim"},{"key":"2023111415103707400_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cellimm.2015.11.008","article-title":"War and peace: factor VIII and the adaptive immune response","volume":"301","author":"Georgescu","year":"2016","journal-title":"Cell Immunol"},{"issue":"3","key":"2023111415103707400_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jth.13936","article-title":"Early cellular interactions and immune transcriptome profiles in human factor VIII-exposed hemophilia A mice","volume":"16","author":"Lai","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2023111415103707400_bib29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2009-03-202267","article-title":"A\u00a0murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells","volume":"114","author":"Matsui","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2023111415103707400_bib30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood-2008-09-174649","article-title":"Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice","volume":"114","author":"Qadura","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2023111415103707400_bib31","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1172\/JCI96400","article-title":"The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity","volume":"128","author":"Swystun","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"2023111415103707400_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jth.14404","article-title":"The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent manner","volume":"17","author":"Swystun","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"2023111415103707400_bib33","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/jth.14521","article-title":"The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen","volume":"17","author":"Swystun","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"2023111415103707400_bib34","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/blood-2015-04-641696","article-title":"Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII","volume":"126","author":"Yee","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2023111415103707400_bib35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3324\/haematol.2017.165720","article-title":"Complement C3 is a novel modulator of the anti-factor VIII immune response","volume":"103","author":"Rayes","year":"2018","journal-title":"Haematologica"},{"issue":"19","key":"2023111415103707400_bib36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/bloodadvances.2017009209","article-title":"The impact of von Willebrand factor on factor VIII memory immune responses","volume":"1","author":"Chen","year":"2017","journal-title":"Blood Adv"},{"issue":"26","key":"2023111415103707400_bib37","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1182\/blood-2015-11-679282","article-title":"Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A","volume":"127","author":"Lai","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2023111415103707400_bib38","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1042\/bj2570679","article-title":"The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII","volume":"257","author":"Leyte","year":"1989","journal-title":"Biochem J"},{"issue":"7","key":"2023111415103707400_bib39","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood-2014-09-598268","article-title":"Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans","volume":"125","author":"Hofbauer","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2023111415103707400_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2516.2007.01484.x","article-title":"Immune tolerance induction with a high purity von Willebrand factor\/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response","volume":"13","author":"Gringeri","year":"2007","journal-title":"Haemophilia"},{"issue":"9","key":"2023111415103707400_bib41","first-page":"1288","article-title":"Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors","volume":"90","author":"Orsini","year":"2005","journal-title":"Haematologica"},{"issue":"6","key":"2023111415103707400_bib42","first-page":"EREP05","article-title":"The role of plasma-derived factor VIII\/von Willebrand factor concentrates in the treatment of hemophilia A patients","volume":"88","author":"Auerswald","year":"2003","journal-title":"Haematologica"},{"issue":"11","key":"2023111415103707400_bib43","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/j.1538-7836.2011.04493.x","article-title":"The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience","volume":"9","author":"Kurth","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2023111415103707400_bib44","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1111\/j.1365-2516.2011.02577.x","article-title":"Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH) in 14 patients with severe haemophilia A","volume":"17","author":"Bidlingmaier","year":"2011","journal-title":"Haemophilia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/21\/6771\/2089270\/blooda_adv-2023-010388-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/21\/6771\/2089270\/blooda_adv-2023-010388-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T10:12:11Z","timestamp":1699956731000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/21\/6771\/498124\/von-Willebrand-factor-modulates-immune-complexes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":44,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023,11,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010388","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]}}}